Abpro Corporation is a clinical-stage biotechnology company focused on developing next-generation antibody therapies to improve the lives of patients with severe and life-threatening diseases. Our proprietary DiversImmune™ platform has successfully targeted over 300 challenging disease targets, and ...See more
Headquarters:
United States of America
Company Type:
SME
Company size:
11-50 Employees
Year Founded:
2007 (18 years)
Address:
68 CUMMINGS PARK DR; WOBURN, MASSACHUSETTS 01801, US
LOW
spending power